文献速递间质性肺疾病

支气管肺泡灌洗液淋巴细胞增多与非IPF间质性肺病的早期糖皮质激素反应

Bronchoalveolar Lavage Lymphocytosis and Early Glucocorticoid Response: A Prospective Study of 150 Subjects With Interstitial Lung Disease.
PubMed 文献 · Respirology · 2025-08-17

本研究前瞻性纳入150例非特发性肺纤维化间质性肺疾病受试者,给予糖皮质激素治疗,以症状与肺功能复合指标定义2个月时的早期糖皮质激素反应(EGR)。结果显示,支气管肺泡灌洗液淋巴细胞百分比(BLP)较高与症状病程较短者更易出现EGR,而BLP低于20%与吸烟暴露则预测6个月时疾病进展。

要点

  • BLP较高与症状病程较短是非IPF间质性肺病患者早期糖皮质激素反应的独立相关因素。
  • BLP低于20%与吸烟暴露独立预测糖皮质激素治疗后6个月疾病进展。
  • 糖皮质激素决策可结合BLP分层与症状病程评估早期反应可能性。

核心结论

  • 较高的BLP与较短症状病程与早期糖皮质激素反应相关。
  • BLP低于20%与吸烟暴露预测尽管接受糖皮质激素治疗仍出现疾病进展。

研究设计与样本

  • 前瞻性研究,纳入150例非IPF间质性肺疾病受试者并给予糖皮质激素治疗。
  • EGR定义为糖皮质激素启动后2个月症状与肺功能测验的复合反应。

主要发现

  • BLP与EGR独立相关(aOR 1.64;95%CI 1.03-2.63;p=0.04)。
  • 症状病程与EGR独立相关(aOR 0.60;95%CI 0.40-0.92;p=0.02)。
  • BLP低于20%独立预测6个月疾病进展(aOR 4.37;95%CI 1.37-13.96;p=0.01)。
  • 吸烟暴露史独立预测6个月疾病进展(aOR 4.59;95%CI 1.25-16.91;p=0.02)。
  • 受试者平均年龄51.2岁,39%为男性,73%为过敏性肺炎或结缔组织病相关ILD。

关键数值与推荐

  • BLP以有序分级表示:0%-19%、20%-29%、30%-39%、≥40%。
  • EGR为糖皮质激素启动后2个月症状与肺功能测验的复合反应。
  • 混杂因素包括年龄、性别、体质指数、吸烟暴露、%pred FVC、症状病程及胸部CT炎症和/或纤维化表型。

临床怎么用

  • 对非IPF间质性肺疾病患者,可参考BLP分级与症状病程评估早期糖皮质激素反应可能性。
  • BLP低于20%或吸烟暴露者应警惕糖皮质激素治疗后6个月疾病进展风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Bronchoalveolar lavage lymphocyte percentage (BLP) is considered a prognostic marker for interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF). Its association with an early glucocorticoid response (EGR) has not been studied systematically. We aimed to assess the association of BLP and other factors with EGR. METHODS: We prospectively enrolled subjects with non-IPF ILDs and treated them with glucocorticoids. We defined EGR as a composite response in symptoms and pulmonary function tests 2 months after glucocorticoid initiation. Cases were those with EGR (responders), while non-responders (without EGR) formed the controls. The primary exposure was the BLP expressed on an ordinal scale: 0%-19%, 20%-29%, 30%-39%, ≥ 40%. Confounders included age, sex, body mass index, smoke exposure, %pred FVC, symptom duration, inflammatory and/or fibrotic phenotype on chest computed tomography. We also assessed factors associated with progressive disease at 6 months. RESULTS: We included 150 subjects (mean age, 51.2 years; 39% men); 73% had either hypersensitivity pneumonitis or connective tissue disease-related ILD. One hundred and thirty-one subjects (69 responders; 62 non-responders) followed up at 2 months. The BLP (adjusted odds ratio [aOR], 1.64; 95% confidence intervals [CI], 1.03-2.63; p = 0.04) and symptom duration (aOR, 0.60; 95% CI, 0.40-0.92; p = 0.02) were independently associated with EGR. A BLP < 20% (aOR, 4.37; 95% CI, 1.37-13.96; p = 0.01) and history of smoke exposure (aOR, 4.59; 95% CI, 1.25-16.91; p = 0.02) independently predicted progressive disease at 6 months. CONCLUSION: Higher BLPs and shorter symptom duration were associated with EGR, while BLP < 20% and smoke exposure predicted progressive disease despite glucocorticoid treatment.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Dhooria S, Rao H, Gupta N, et al. Bronchoalveolar Lavage Lymphocytosis and Early Glucocorticoid Response: A Prospective Study of 150 Subjects With Interstitial Lung Disease. Respirology. 2025. PMID: 40820187. doi:10.1111/resp.70105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。